`
`United STATES PATENT AND TRADEMARK OFFICE
`____________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`AUROBINDO PHARMA USA, INC.,
`Petitioner,
`v.
`ANDRX LABS, LLC,
`TEVA PHARMACEUTICAL USA INC., AND SHIONOGI INC.,
`Patent Owner.
`____________
`Case IPR2017-01648
`Patent 6,866,866 B1
`____________
`Mailed: June 22, 2017
`Before Lawrence J. Banks, Trial Paralegal.
`
`
`
`RESPONSE TO JULY 12, 2017 NOTICE OF FILING DATE ACCORDED TO
`PETITION AND
`
`TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE
`
`
`
`GW00911/0083-US-5755029/1
`
`1.
`
`
`
`
`
`
`
`
`
`
`CERTIFICATE OF COMPLIANCE
`
`Petitioner was informed that the Petitioner did not include a certification
`stating the number of words in its petition, per 37 C.F.R. §§ 42.6, 42.24. A corrected
`certification of word count is submitted herein.
`
`Pursuant to 37 C.F.R. §42.24(d), the undersigned certifies that this Corrected
`Petition complies with the type-volume limitation of 37 C.F.R. §42.24(a). The
`word count application of the word processing program used to prepare this
`Petition indicates that the Petition contains 14,000 words, or less, excluding the
`parts of the brief exempted by 37 C.F.R. §42.24(a).
`
`
`July 18, 2017
`
`
`
`
`
`
`
`
`
`By /Steven J. Moore/
`Steven J. Moore
`Reg. No. 35,959
`WITHERS BERGMAN
`Suite 400
`1700 East Putnam Avenue
`Old Greenwich, CT 06870
`Tel: (203) 302-4069
`Fax: (203) 302-6609
`Counsel for Aurobindo Pharma, USA, Inc.
`
`GW00911/0083-US-5755029/1
`
`2.
`
`
`
`